Loncin Motor (603766.SS) traded flat 0 % during a 24 hours period ending at 11:28 PM Central Europe on Monday 26th. One Loncin Motor stock can currently be bought for about CNY 15.79 on popular exchanges. Current supply of Loncin Motor stocks is 2.1 bn. Loncin Motor has a current market capitalization of CNY 31.3 bn and approximately CNY 405.1 mn worth of Loncin Motor was traded on exchanges in the last 24 hours. Since last month end, Loncin Motor has traded 4.67 % up. Simple moving average of last 200 days is at CNY 13.66. The highest price of past 52 weeks was recorded at CNY 16.78 on 02/25/2026. 52 weeks low was at CNY 10.84 on 06/22/2026.

Summary of the latest news for Loncin Motor

LONCIN MOTOR CO LTD reported its latest quarterly earnings, highlighting a continued focus on product development and operational efficiency. The company noted that its 2026 financial performance had been impacted by competitive pricing and regulatory negotiations in key markets. Management emphasized ongoing efforts to introduce new products, expand international distribution, and enhance business processes. While revenue growth remained stable compared with the first half of the year, the company expects a narrower decline in profitability for the full year, aligning more closely with its income trajectory. This update reflects LONCIN MOTOR’s commitment to maintaining steady growth and improving financial outcomes despite market pressures.

Here is how related stocks have performed in the past 24 hours:

  • Jchx Mining Management (603979.SS) traded flat 0 % and now trades at CNY 57.19. Current market capitalisation for Jchx Mining Management is CNY 37 bn. Current price/earnings ratio for Jchx Mining Management is 13.8.

  • Zoomlion Heavy Industry - H (1157.HK) traded down -0.29 % and now trades at HKD 5.08. Current market capitalisation for Zoomlion Heavy Industry - H is HKD 43.8 bn. Current price/earnings ratio for Zoomlion Heavy Industry - H is 7.7. Zoomlion Heavy Industry – H reported a positive outlook for its shares after the company announced that its financial results for the quarter were stronger than analysts had expected. The company cited a combination of rising sales volume, improved margin performance and a favorable macro‑environment as key drivers. In addition, Zoomlion highlighted ongoing investments in its research and development pipeline, particularly in electrification and digitalisation of its product lines. The management team reaffirmed its commitment to returning value to shareholders through a disciplined approach to capital allocation, while noting that the current market conditions provide a supportive backdrop for continued growth. Overall, the announcement reinforced investor confidence in Zoomlion’s strategy and operational execution.

  • Apt Medical (688617.SS) traded flat 0 % and now trades at CNY 279.99. Current market capitalisation for Apt Medical is CNY 37.3 bn. Apt Medical has a current price to earnings ratio of 40.3. APT MEDICAL INC has announced a series of operational updates during the latest reporting period. The company highlighted a continued expansion of its minimally invasive medical device portfolio, noting an increase in market coverage and an ongoing strengthening of its research and development capabilities. Management indicated that production capacity remains stable, with supply chains secure and utilisation rates high, supporting the company’s ability to meet growing demand. The company also reiterated its commitment to digital and intelligent upgrades, aiming to enhance product performance and broaden international market reach. In line with corporate governance practices, APT MEDICAL INC has maintained regular dividend payments and share‑repurchase activities, reinforcing confidence among investors and signalling a solid financial position.

  • Shanghai Fosun Pharmaceuti-h (2196.HK) traded up 1.35 % and now trades at HKD 16.66. Current market capitalisation for Shanghai Fosun Pharmaceuti-h is HKD 44 bn. Shanghai Fosun Pharmaceuti-h has a current price to earnings ratio of 11.21. Shanghai Fosun Pharmaceutical (Group) announced its most recent quarterly results at a three‑month financial conference. Analysts expected a modest rise in earnings per share and revenue compared to the previous year, with the company’s performance seen as solid but not transformative. Forecasts for the full fiscal year projected continued growth in both profit and sales, reflecting a positive trajectory for the group. The disclosure also highlighted forthcoming industry data releases and regulatory changes affecting the broader market. Overall, the company’s update reinforced its steady position within the pharmaceutical sector, indicating incremental gains rather than dramatic shifts in financial performance.

  • Bilibili (9626.HK) traded up 2.61 % and now trades at HKD 105.8. Current market capitalisation for Bilibili is HKD 43.7 bn. Current price/earnings ratio for Bilibili is 27.17.

About Loncin Motor

Loncin Motor Co. Ltd. is a company based in Chongqing, China that specializes in manufacturing motorcycles and other vehicles. They develop, produce, and sell motorized two wheel vehicles, motorized three wheel vehicles, engines, generators, and new-energy cars. As a global company, Lonsin Motor provides its products all around the world. You can learn more about their offerings by visiting their website at www.loncinindustries.com . The stock of this consumer discretionary industry company is traded on the Shanghai Stock Exchange. The IPO for this company took place on August 10, 2012.